Performance status assessment in cancer patients. An inter-observer variability study.
about
Moving beyond Karnofsky and ECOG Performance Status Assessments with New TechnologiesGrey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons' perspectiveBringing Patient-Centered Care to the Fore in Diseases of the PancreasStaging of hepatocellular carcinomaThe role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study.EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre.Factors influencing treatment selection and survival in advanced lung cancerLeukocyte Telomere Length and Serum Levels of High-Molecular-Weight Adiponectin and Dehydroepiandrosterone-Sulfate Could Reflect Distinct Aspects of Longevity in Japanese Centenarians.Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and designHepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival.Dyadic influence of hope and optimism on patient marital satisfaction among couples with advanced breast cancer.The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study.TACE performed in patients with a single nodule of hepatocellular carcinoma.Percutaneous ablation of hepatic tumors.Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review.Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma.Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic.Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.Unmet needs of breast cancer patients relative to survival duration.The Functionality Assessment Flowchart (FAF): a new simple and reliable method to measure performance status with a high percentage of agreement between observers.Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.Gram-stain-based antimicrobial selection reduces cost and overuse compared with Japanese guidelines.Pre-radiotherapy Haemoglobin Level is A Prognosticator in Locally Advanced Head and Neck Cancers Treated with Concurrent Chemoradiation.A phase II double-blinded study to evaluate the efficacy of EW02 in reducing chemotherapy-induced neutropenia in breast cancer.Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis.Early versus Delayed Therapy of Advanced Gastric Cancer Patients--Does It Make a Difference?The Danish Neuro-Oncology Registry: establishment, completeness and validity.The risk of burn injury during long-term oxygen therapy: a 17-year longitudinal national study in Sweden.Selection of patients with hepatocellular carcinoma for liver transplantation.Factors associated with malnutrition in hospitalized cancer patients: a croos-sectional studyUnmet Needs and Their Relationship with Quality of Life among Women with Recurrent Breast Cancer.Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer.Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses.Performance status score: do patients and their oncologists agree?Collision tumor consisting of primary follicular lymphoma and adenocarcinoma in the cecum: A case report and literature review.Does chemotherapy really affect the quality of life of women with breast cancer?Current status of percutaneous endoscopic gastrostomy (PEG) in a general hospital in Japan: a cross-sectional studyMultivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization.Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy.Validation and optimization of a predictive model for radiation pneumonitis in patients with lung cancer
P2860
Q26749492-F0F3D1CA-2E63-4353-99F7-55F057155CAAQ26799052-89B8EF6D-873C-4D8A-948B-35986550858BQ26830174-4D6CFDF1-D7B4-43B7-9E92-371B4E4EF706Q28081265-09B616EB-E53B-4D3E-8607-0011E5F7935CQ30830775-58EF6B9D-AEF9-4B3A-951A-DA3C071523C2Q31124402-F7E77C0A-F107-44AB-AE46-2ED95170F9B8Q33611139-9F5480CE-DCE6-4EB6-AFB4-AF44B7A4CFF3Q33693554-E8889FA2-9089-4262-A80B-C9C78175B9EAQ33741041-1E90442D-2925-4A42-BB06-18AB927438ABQ33845513-725EF319-3866-49E2-84E1-750E081216D9Q33992295-67B053E4-D1A7-4945-BA90-036B16332D50Q33994360-A3ECA97A-2B97-4FB9-BE3F-1B235B8990A6Q34136129-01F393E8-98FA-48A1-9C33-5DF4A0F1A942Q34253356-701CB595-5991-4F7F-8F0D-024D16D03D12Q34623730-64F0427A-8510-4B6A-AB6C-E6086CA71287Q35145063-6DBCCA1C-56CA-428D-9541-E40512E863DEQ35559782-46136ADE-1F73-47EE-BD00-9B4FB7219200Q35597241-8D450695-DE4D-43C1-8276-B2D72D06AD90Q35648266-66ABFFB5-BFF7-4CDF-9F7B-588125C6C4CAQ35682728-68D25B7B-1B63-47D6-9226-A687F4A98778Q35708619-44134014-6295-4862-9FB8-BABBE82248EBQ35822009-CD27E725-D088-4D33-8F7B-70A8C1960A04Q35918273-DCBB081E-DAFB-4CFB-9A5A-4AB82844368AQ35944576-84F111C5-6AD3-49D8-B97D-A1B6D516DE7AQ36076614-0ACED878-9FE7-480D-ACB0-880D0473E6E6Q36087032-B42A0D0E-7A33-4429-9D5A-67567C0C25ECQ36117342-DA0BA334-E953-47C5-B7E5-C9DF1CEEA138Q36303267-957FA156-6466-4C57-B1AF-6A6748938BDBQ36331568-B43F88BC-8C19-478A-A1B4-C89A8667F3DAQ36364343-EA3A34FB-CC44-46CE-A7DB-5D71F35FB208Q36525844-38B58DF8-93F6-4D5A-AD60-92C36BBB387CQ36623216-09C948A0-6093-4517-8987-EE0608DB22DCQ36641177-C9FCB7E4-F80D-4380-9F9B-56819114AAAFQ36648445-238E6D79-15E5-4D60-AF7D-573F8DC6F2A2Q36740855-9BCFB672-C9D2-48CB-A437-ADB9CF7D33A5Q36998153-8845D438-2FCC-4EC5-BFB0-E0D5088AC2E0Q37010356-4AB1B138-C7DF-4901-9912-7B3FF5659291Q37063190-2CD466AA-4815-4BE6-AFCB-64AC72298438Q37098187-04F9E70B-8936-4811-9627-09C1B73A7082Q37106816-EDDC54FE-255B-45B7-BE4F-DA809F74180A
P2860
Performance status assessment in cancer patients. An inter-observer variability study.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Performance status assessment in cancer patients. An inter-observer variability study.
@ast
Performance status assessment in cancer patients. An inter-observer variability study.
@en
type
label
Performance status assessment in cancer patients. An inter-observer variability study.
@ast
Performance status assessment in cancer patients. An inter-observer variability study.
@en
prefLabel
Performance status assessment in cancer patients. An inter-observer variability study.
@ast
Performance status assessment in cancer patients. An inter-observer variability study.
@en
P2093
P2860
P356
P1476
Performance status assessment in cancer patients. An inter-observer variability study.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1993.140
P407
P577
1993-04-01T00:00:00Z
P5875
P6179
1042277183